Fraser Wares is a trained Public Health Physician, working at KNCV as a Senior Consultant (PMDT) since March 2016. Under the Challenge TB project (up to October 2019), his main focus was on the “New Drugs and Regimens Initiative” for drug-resistant TB (DR-TB) patients. Since then his focus has continued to be on the introduction of new drugs and regimens for DR-TB patients, especially the 6-9 month all oral BPaL regimen.
He has worked on TB control for over 25 years in Africa, Asia and Europe, including 14 years of working for the World Health Organisation’s (WHO) Global TB Programme (8 years in India and 6 years in Geneva, Switzerland). For the last 15 years, his area of interest and work has focused on DR-TB and the programmatic management of DR-TB (PMDT), and supporting countries to expand their PMDT services and care, via contributing to global level policy development, in-country capacity building activities, and via the work of the Green Light Committees and the Global Drug Resistant TB Initiative. He has co-authored over 100 publications in international and national scientific journals, and textbooks, and has contributed to the development of a number of WHO global policy documents, mainly related to PMDT and DR-TB.
